Sakiko Yamada

6PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Orthodontics and dentofacial orthopaedics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 22, 2024
A multicenter, single-arm, open-label interventional study of adherence to brexpiprazole during switching from previous antipsychotic drugs in patients with schizophrenia or schizoaffective disorder.

Kazuyuki Nakagome, Hisateru Tachimori, Shiro Endo

|Jul 29, 2022
Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study.

Akitoyo Hishimoto, Norio Yasui-Furukori, Daisuke Sekine

|Mar 29, 2021
Real-World Treatment Patterns and Adherence to Oral Medication Among Patients with Bipolar Disorders: A Retrospective, Observational Study Using a Healthcare Claims Database.

Takeshi Inoue, Hiromi Sano, Yoshitsugu Kojima

|Jan 26, 2021
Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study.

Jun Ishigooka, Ken Inada, Kazunari Niidome

|Dec 30, 2020
Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist's Perspective.

Yoshinori Watanabe, Sakiko Yamada, Tempei Otsubo

|Oct 29, 2020
Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study.

Ken Inada, Sakiko Yamada, Hisashi Akiyoshi

Pageof 1

Frequent Collaborators

2 joint publications

Ken Inada

2 joint publications

Shuichi Iwashita

2 joint publications

Kazunari Niidome

1 joint publications

Takeshi Inoue